Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anthrax Infection”

80 trials

Showing 20 of 80 results

Post-approval studies (Phase 4)Study completedNCT01641991
What this trial is testing

Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 328
Not applicableActive Not RecruitingNCT07220031
What this trial is testing

Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay

Who this might be right for
Osmolality DisturbanceLab Interference
State University of New York - Upstate Medical University 8
Not applicableNot Yet RecruitingNCT03569553
What this trial is testing

A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients

Who this might be right for
Inhalational Anthrax
Emergent BioSolutions 100
Early research (Phase 1)Study completedNCT01952444
What this trial is testing

Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers

Who this might be right for
Inhalational Anthrax
Elusys Therapeutics 40
Testing effectiveness (Phase 2)Study completedNCT01624532
What this trial is testing

Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109

Who this might be right for
Anthrax
Green Cross Corporation 240
Not applicableStudy completedNCT01690559
What this trial is testing

Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without Dilution

Who this might be right for
Infection
Bayer 704
Early research (Phase 1)Study completedNCT04767776
What this trial is testing

Non Inferiority Study of a Reduced Dose of Activated Charcoal on Rivaroxaban Pharmacokinetics.

Who this might be right for
Healthy
Centre Hospitalier Universitaire de Saint Etienne 12
Not applicableStudy completedNCT03498027
What this trial is testing

Febrile Whole Blood Specimen Collection and Testing

Who this might be right for
Febrile InfectionAnthrax
MRI Global 97
Testing effectiveness (Phase 2)Study completedNCT04067011
What this trial is testing

Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study

Who this might be right for
Anthrax
Emergent BioSolutions 210
Testing effectiveness (Phase 2)Study completedNCT01794182
What this trial is testing

Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals

Who this might be right for
Ischemic StrokeMalignant Edema
Remedy Pharmaceuticals, Inc. 86
Early research (Phase 1)Study completedNCT03352466
What this trial is testing

NasoShield Study of Safety and Immunogenicity

Who this might be right for
Healthy Volunteers
Altimmune, Inc. 145
Not applicableStudy completedNCT00050310
What this trial is testing

Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients

Who this might be right for
AnthraxBacillus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 15
Not applicableStudy completedNCT00123396
What this trial is testing

VHA Clinicians and Bioterror Events: Interactive Web-based Learning

Who this might be right for
SmallpoxAnthrax
US Department of Veterans Affairs 15
Early research (Phase 1)Study completedNCT00448253
What this trial is testing

Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum

Who this might be right for
Symptoms of Inhalational Anthrax
Emergent BioSolutions 92
Not applicableEnded earlyNCT03321903
What this trial is testing

EPR Tumor Oximetry With CE India Ink

Who this might be right for
Neoplasms, MalignantBreast NeoplasmCarcinoma, Basal Cell+4 more
Philip Schaner 3
Not applicableUnknownNCT06365073
What this trial is testing

A Case-control Study on the Clinical Characteristics of 28-day and 90-day Death From Severe Anthrax

Who this might be right for
Anthrax
Qin Ning 80
Early research (Phase 1)Study completedNCT01929226
What this trial is testing

Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers

Who this might be right for
Inhalational Anthrax
Elusys Therapeutics 280
Early research (Phase 1)Study completedNCT01265745
What this trial is testing

Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects

Who this might be right for
Anthrax
PharmAthene, Inc. 28
Early research (Phase 1)Study completedNCT02657512
What this trial is testing

Effect of Activated Charcoal on Rivaroxaban Pharmacokinetics in Healthy Subjects

Who this might be right for
Healthy
Centre Hospitalier Universitaire de Saint Etienne 12
Not applicableStudy completedNCT00031291
What this trial is testing

Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin

Who this might be right for
Anthrax
National Institutes of Health Clinical Center (CC) 400
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation